BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/11/2018 10:09:37 AM | Browse: 805 | Download: 936
 |
Received |
|
2017-11-22 17:16 |
 |
Peer-Review Started |
|
|
|
To Make the First Decision |
|
2017-12-07 00:25 |
|
Return for Revision |
|
2017-12-07 01:14 |
|
Revised |
|
2017-12-19 14:53 |
|
Second Decision |
|
2017-12-28 10:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-02-05 23:24 |
|
Articles in Press |
|
2018-02-05 23:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-02-13 20:15 |
|
Typeset the Manuscript |
|
2018-03-26 14:38 |
|
Publish the Manuscript Online |
|
2018-04-11 01:34 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Marco Galvez, Carlos A Castaneda, Joselyn Sanchez, Miluska Castillo, Lia Pamela Rebaza, Gabriela Calderon, Miguel De La Cruz, Jose Manuel Cotrina, Julio Abugattas, Jorge Dunstan, Henry Guerra, Omar Mejia and Henry L Gomez |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Carlos A Castaneda, MD, MSc, Assistant Professor, Medical Oncology Department, Instituto Nacional de Enfermedades Neoplasicas, Av. Angamos Este 2520 Surquillo, Lima 15038, Peru. ccastaneda@inen.sld.pe |
| Key Words |
Breast cancer; Subtype; Tumor-infiltrating lymphocytes; Neoadjuvant therapy; Pathological complete response; Survival |
| Core Tip |
The authors evaluated a series of 435 breast cancer (BC) patients who received neoadjuvant chemotherapy. They evaluated the association between stromal tumor-infiltrating lymphocytes levels and pCR in preneoadjuvant chemotherapy samples according to molecular subtypes. The results confirm differences in the predictive and prognostic role of stromal tumorinfiltrating lymphocytes and pathological complete response depending on the tumor subtype. Additionally, the authors evaluate the value of traditional prognostic features in every BC subset. The results increase the understanding of biomarkers in the heterogeneous scenario of BC. |
| Publish Date |
2018-04-11 01:34 |
| Citation |
Galvez M, Castaneda CA, Sanchez J, Castillo M, Rebaza LP, Calderon G, De La Cruz M, Cotrina JM, Abugattas J, Dunstan J, Guerra H, Mejia O, Gomez HL. Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant
chemotherapy. World J Clin Oncol 2018; 9(2): 33-41 |
| URL |
http://www.wjgnet.com/2218-4333/full/v9/i2/33.htm |
| DOI |
http://dx.doi.org/10.5306/wjco.v9.i2.33 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
